Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company ...

Crescent Biopharma is an early-stage biotech with a promising PD-1/VEGF bispecific antibody. Read why I rate CBIO stock as a ...

Key Takeaways from the Metastatic Castration-Resistant Prostate Cancer Pipeline Report ...

The implications are huge. Bladder cancer ranks as the sixth most common cancer in the U.S., affecting around 80,000 people ...